Stay updated on Incyte Press Releases

Sign up to get notified when there's something new on the Incyte Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Incyte Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    The press-release list now features Incyte’s October 29, 2026 third-quarter financial results and business updates; the displayed release count increases from 44 to 45, and the July 29 Opzelura approval announcement is no longer in the listed entries.
    Difference
    1%
    Check dated 2026-11-03T23:00:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The latest Incyte press releases now include announcements about gastrointestinal cancer data at ESMO 2026 and a clinical-trial collaboration with Genmab in metastatic colorectal cancer. The listing now displays 44 releases, replacing two older entries, including the second-quarter financial results announcement.
    Difference
    5%
    Check dated 2026-10-27T23:02:14.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The listing adds Incyte’s October 18, 2026 announcement about key oncology data presentations at the ESMO Congress and removes its July 13 release on VGA039 multidose data at ISTH 2026. The displayed release total increases from 41 to 42.
    Difference
    1%
    Check dated 2026-10-20T22:09:15.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Two October 2026 releases were added: an announcement honoring the 2026 MPN Heroes and notice of Incyte’s upcoming third-quarter financial results. Two July 2026 releases were removed from the displayed list, and the archive count increased from 39 to 41.
    Difference
    5%
    Check dated 2026-10-13T22:06:32.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Adds a new press release announcing the U.S. FDA approval of Atebrioz (zilurgisertib) for adult and pediatric patients with Fibrodysplasia Ossificans Progressiva, dated September 25, 2026. Removes the listing for a press release about a CHMP opinion for Opzelura (ruxolitinib) Cream for adults with moderate atopic dermatitis, dated June 26, 2026.
    Difference
    1%
    Check dated 2026-09-29T22:32:45.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new press release entry about Incyte's data at the EADV Congress was added (dated September 22, 2026) and an older release about Minjuvi approval in Japan was removed; the total number of displayed releases updated from 37 to 38.
    Difference
    1%
    Check dated 2026-09-22T23:16:59.000Z thumbnail image

Stay in the know with updates to Incyte Press Releases

Enter your email address, and we'll notify you when there's something new on the Incyte Press Releases page.